fashion -WSS

fashion

author：Wikipedia 2025-09-30 09:57:11 - browse：55

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： CDC says it’s too soon to assess risk posed by Covid subvariant

entertainment

WSS

HPV cancer vaccine study demonstrates efficacy

STAT Executive Editor Rick Berke on STAT's 8th birthday

White House calls on federal agencies to crack down on AI abuses

Hospital at home shows how to bring innovation to health care

Former Pear Therapeutics executives start new VC firm

Health officials lay out plans to cope with respiratory virus season

focus

fashion

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Kellogg’s is going to war over Mexico’s nutrition label rules

Wildfire smoke exposes gaps in outdoor worker protections

PBMs are inflating the cost of generic drugs. They must be reined in

Duchenne breakthrough therapy leaves behind pioneering families

FDA approves Recor Medical high blood pressure device

How one medical school became remarkably diverse

People can get long Covid without testing positive for virus: Study

Guidelines to prevent youth baseball injuries need more muscle

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

focus

More doctors should go into startup world

Trans patients at the end of life deserve respect and dignity

Listen: Vivek Ramaswamy's star turn & leaky drug data

AstraZeneca CEO says participant had neurological symptoms, could be discharged today

Medicare solvency divides Republicans at the presidential debate

Excited delirium, Elijah McClain, and emergency physicians

focus

entertainment

leisure time

focus